跳至主要内容
临床试验/NCT02604719
NCT02604719Unknown1 期

Tranexamic Acid and Ethamsylate For Preventing Post Partum Hemorrhage in Patient Undergoing LSCS at High Risk For Post PartumHemorrhage : A Randomized Controlled Trial

Ahmed Alanwar0 个研究点目标入组 64 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
64
主要终点
PPH defined as blood loss ≥500 cc

研究概览

简要总结

The aim of this study is to compare the effect of low dose of Tranexamic acid (1gm) and Ethamsylate (1gm) after prophylactic oxytocin administration versus placebo with prophylactic oxytocin given in the 2 minutes after child delivery in patient undergoing LSCS at high risk for post partum hemorrhage

详细描述

Research Question:

Is the combination of Tranexamic acid and Ethamsylate is more effective than oxytocin alone for preventing postpartum hemorrhage if they are given after delivery of the fetus ?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women undergoing elective caesarean section
  • Patient having one or more risk factor for PPH
  • Multiple pregnancy
  • Polyhydramnios (AFI >25cm)
  • Macrocosmic baby (>4.5 Kg)
  • Prolonged , augmented and obstructed labour
  • Obese patients(BMI >30)
  • Premature rapture of membranes
  • Previous history of PPH
  • Age ≥18 years
  • Gestational Age ≥ 35 Weeks
  • Informed Oral Consent From The Patient

排除标准

  • History of venous thrombosis (DVT and/or Pulmonary embolism) OR arterial thrombosis (angina pectoris , myocardial infarction, stroke)
  • History of epilepsy or seizure
  • Any Known Cardiovascular , renal or liver Disease
  • Autoimmune Diseases
  • Sickle Cell Disease
  • Severe hemorrhagic Disease
  • Placenta Previa.
  • Morbidly adherent Placenta
  • Abruptio placenta
  • Eclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome
  • Administration Of low molecular weight heparin or Anti platelets the week before delivery .

研究组 & 干预措施

tanexamic acid and Ethamsylate

Experimental

10 ml of the study drugs (1 gm Tranexamic acid and 1 gm Ethamsylate ) slowly (over 30-60 sec ) in the 2 minutes after birth

干预措施: Tranexamic Acid and Ethamsylate (Drug)

placebo

Placebo Comparator

10 ml normal saline will be administered intravenously just after birth

干预措施: Tranexamic Acid and Ethamsylate (Drug)

结局指标

主要结局

PPH defined as blood loss ≥500 cc

时间窗: the first 24hours

measured by pads placed under women buttocks

次要结局

  • severe PPH (>1000 cc), .(first 24 hours)

研究者

发起方
Ahmed Alanwar
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ahmed Alanwar

dr.ahmed alanwar

Ain Shams University

相似试验